Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Jove

Showing results (81-90 of 90) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 90 results.
Proceedings of the National Academy of Sciences of the United States of America|June 19, 2001
Stat3-mediated Myc expression is required for Src transformation and PDGF-induced mitogenesisT Bowman, M A Broome, D Sinibaldi, et al.
Nature Genetics|February 13, 1999
Activating SRC mutation in a subset of advanced human colon cancersR B Irby, W Mao, D Coppola, et al.
Molecular and Cellular Biology|October 19, 1999
Requirement for Ras/Rac1-mediated p38 and c-Jun N-terminal kinase signaling in Stat3 transcriptional activity induced by the Src oncoproteinJ Turkson, T Bowman, J Adnane, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 8, 2001
Cooperative regulation of Mcl-1 by Janus kinase/stat and phosphatidylinositol 3-kinase contribute to granulocyte-macrophage colony-stimulating factor-delayed apoptosis in human neutrophilsP K Epling-Burnette, B Zhong, F Bai, et al.
Oncogene|September 24, 2013
miR-26a enhances miRNA biogenesis by targeting Lin28B and Zcchc11 to suppress tumor growth and metastasisX Fu, Z Meng, W Liang, et al.
The American Journal of Pathology|August 4, 2001
AKT1/PKBalpha kinase is frequently elevated in human cancers and its constitutive activation is required for oncogenic transformation in NIH3T3 cellsM Sun, G Wang, J E Paciga, et al.
Immunity|February 19, 1999
Constitutive activation of Stat3 signaling confers resistance to apoptosis in human U266 myeloma cellsR Catlett-Falcone, T H Landowski, M M Oshiro, et al.
The Journal of Clinical Investigation|February 13, 2001
Inhibition of STAT3 signaling leads to apoptosis of leukemic large granular lymphocytes and decreased Mcl-1 expressionP K Epling-Burnette, J H Liu, R Catlett-Falcone, et al.
Leukemia|December 18, 2010
The novel JAK inhibitor AZD1480 blocks STAT3 and FGFR3 signaling, resulting in suppression of human myeloma cell growth and survivalA Scuto, P Krejci, L Popplewell, et al.
Oncogene|June 23, 2001
Constitutive activation of Stat3 by the Src and JAK tyrosine kinases participates in growth regulation of human breast carcinoma cellsR Garcia, T L Bowman, G Niu, et al.
Pageof 9

Showing results (81-90 of 90) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 90 results.
Proceedings of the National Academy of Sciences of the United States of America|June 19, 2001
Stat3-mediated Myc expression is required for Src transformation and PDGF-induced mitogenesisT Bowman, M A Broome, D Sinibaldi, et al.
Nature Genetics|February 13, 1999
Activating SRC mutation in a subset of advanced human colon cancersR B Irby, W Mao, D Coppola, et al.
Molecular and Cellular Biology|October 19, 1999
Requirement for Ras/Rac1-mediated p38 and c-Jun N-terminal kinase signaling in Stat3 transcriptional activity induced by the Src oncoproteinJ Turkson, T Bowman, J Adnane, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 8, 2001
Cooperative regulation of Mcl-1 by Janus kinase/stat and phosphatidylinositol 3-kinase contribute to granulocyte-macrophage colony-stimulating factor-delayed apoptosis in human neutrophilsP K Epling-Burnette, B Zhong, F Bai, et al.
Oncogene|September 24, 2013
miR-26a enhances miRNA biogenesis by targeting Lin28B and Zcchc11 to suppress tumor growth and metastasisX Fu, Z Meng, W Liang, et al.
The American Journal of Pathology|August 4, 2001
AKT1/PKBalpha kinase is frequently elevated in human cancers and its constitutive activation is required for oncogenic transformation in NIH3T3 cellsM Sun, G Wang, J E Paciga, et al.
Immunity|February 19, 1999
Constitutive activation of Stat3 signaling confers resistance to apoptosis in human U266 myeloma cellsR Catlett-Falcone, T H Landowski, M M Oshiro, et al.
The Journal of Clinical Investigation|February 13, 2001
Inhibition of STAT3 signaling leads to apoptosis of leukemic large granular lymphocytes and decreased Mcl-1 expressionP K Epling-Burnette, J H Liu, R Catlett-Falcone, et al.
Leukemia|December 18, 2010
The novel JAK inhibitor AZD1480 blocks STAT3 and FGFR3 signaling, resulting in suppression of human myeloma cell growth and survivalA Scuto, P Krejci, L Popplewell, et al.
Oncogene|June 23, 2001
Constitutive activation of Stat3 by the Src and JAK tyrosine kinases participates in growth regulation of human breast carcinoma cellsR Garcia, T L Bowman, G Niu, et al.
Pageof 9